BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Somatic Cell Gene Editing - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Somatic Cell Gene Editing
X-ORIGINAL-URL:https://scge.mcw.edu
X-WR-CALDESC:Events for Somatic Cell Gene Editing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240919
DTEND;VALUE=DATE:20240921
DTSTAMP:20260421T081505
CREATED:20240808T143712Z
LAST-MODIFIED:20240808T143712Z
UID:4358-1726704000-1726876799@scge.mcw.edu
SUMMARY:HI-POCT 2024
DESCRIPTION:IEEE-EMBS International Conference on Health Innovations in Point of Care Technology (IEEE HI-POCT) is the premier conference in the areas of Health innovations in point-of-care technologies. In its eighth year\, this IEEE EMB Strategic Conference will emphasize funding opportunities and the promise and pitfalls of the journey from idea to patient. The conference will provide a strategic forum in which clinicians\, industry experts\, innovation experts\, researchers\, and students will examine how to define unmet clinical needs and successfully travel along the innovation cycle toward commercialization and patient impact. Clinical\, technological\, regulatory\, and marketing aspects of this learnable process will be stressed. Expert panels will discuss learnings in the development\, translation\, and commercialization of technologies and challenges in bringing medical care innovation to community health. \nTuscon\, AZ \n\nHome \n\n 
URL:https://scge.mcw.edu/events/hi-poct-2024/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-093624.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240920T073000
DTEND;TZID=America/Chicago:20240920T173000
DTSTAMP:20260421T081505
CREATED:20240710T134050Z
LAST-MODIFIED:20240710T134155Z
UID:4307-1726817400-1726853400@scge.mcw.edu
SUMMARY:The Safe and Effective Practice of AAV Gene Therapy
DESCRIPTION:Join the Clinical In Vivo Gene Therapy (CIGT) team at Children’s Hospital of Philadelphia for an exciting one-day educational symposium\, as we provide fundamental knowledge on the safe and effective practice of adeno-associated virus (AAV) gene therapy across medical specialties. SCGE researchers Lindsey George\, Beverly Davidson\, and Rebecca Ahrens-Nicklas are scheduled to be speaking at the event. \nFriday September 20\, 2024 || Philadelphia\, PA \nView the registration info here
URL:https://scge.mcw.edu/events/the-safe-and-effective-practice-of-aav-gene-therapy/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/07/Screenshot-2024-07-10-083625.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240920T100000
DTEND;TZID=America/Chicago:20240920T153000
DTSTAMP:20260421T081505
CREATED:20240723T134352Z
LAST-MODIFIED:20240723T134352Z
UID:4333-1726826400-1726846200@scge.mcw.edu
SUMMARY:Meeting 1: Patient and Care Partner Perspectives on Safety Considerations for Approved Gene Therapy Treatments for Rare Diseases
DESCRIPTION:The FDA Center for Biologics Evaluation and Research (CBER) is hosting a public patient listening meeting and opening a docket to better understand patient and care partner perspectives on safety considerations and long-term follow-up for approved gene therapy treatments for rare diseases. \nThe objectives of this listening meeting are to hear from patients and care partners on their perspectives on short-term and long-term risks of approved gene therapy products\, to learn what types of information patients would find helpful in their decision-making when considering gene therapy\, to learn about their considerations and experience with participating in long-term studies after receiving a gene therapy\, and to help inform patient-centered protocols for long-term studies that include gene therapy outcomes.  The meeting will be divided into two sessions. \nRegister for the Zoom meeting here: https://web.cvent.com/event/0b2da86e-f7d1-4288-9d11-2cb9cabe87c5/regProcessStep \nRegistration will close on Thursday\, September 19\, 2024\, at 11:59 pm ET. A recording and other relevant meeting materials will be posted online following the event.
URL:https://scge.mcw.edu/events/meeting-1-patient-and-care-partner-perspectives-on-safety-considerations-for-approved-gene-therapy-treatments-for-rare-diseases/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/07/Screenshot-2024-07-23-084318.png
END:VEVENT
END:VCALENDAR